ProMIS Neurosciences Inc.
PMN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001374339
In the last 90 days, ProMIS Neurosciences Inc. insiders filed 1 open-market purchase and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $84.3M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding ProMIS Neurosciences Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 16 | 16 | 0 |
| Shares | 3.38M | 3.26M | −120.3K (−3.6%) |
| Value | $6.46M | $4.90M | −$1.56M (−24.1%) |
New holders (2)
Institutions that held ProMIS Neurosciences Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| TD Waterhouse Canada Inc. | 133 | $202 | 0.00% |
| Wells Fargo & Company | 20 | $30 | 0.00% |
Sold out (2)
Institutions that held ProMIS Neurosciences Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Northeast Financial Consultants Inc | 100,000 | $191.0K |
| UBS Group AG | 250 | $478 |